Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Napabucasin in advanced colorectal cancer
NCT01776307Phase 2Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Mar 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of napabucasin in colorectal cancer (CRC), sponsored by Sumitomo Pharma America. Started Mar 2012; status: completed.
02
Drugs
napabucasin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01776307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01776307.